Medindia LOGIN REGISTER
Medindia

Artificial Pancreas Smartphone App: Positive Trial Results Reported

by Colleen Fleiss on Jan 28 2019 3:06 AM

Scientists have reported the safety and efficacy of the interoperable Artificial Pancreas System smartphone app (iAPS).

Artificial Pancreas Smartphone App: Positive Trial Results Reported
Scientists have reported the safety and efficacy of the interoperable Artificial Pancreas System smartphone app (iAPS). The app can interface wirelessly with leading continuous glucose monitors (CGM), insulin pump devices, and decision-making //algorithms.
The clinical trial and the app, which runs on an unlocked smartphone, are described in an article published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Click here to read the full-text article free on the Diabetes Technology & Therapeutics (DTT).

Eyal Dassau, Harvard University (Cambridge, MA), Sansum Diabetes Research Institute (Santa Barbara, CA), and Joslin Diabetes Center (Boston, MA), and colleagues from these institutions and Labrasoft LLC (Leander, TX) coauthored the article entitled "Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development."

"Interoperability is so important with artificial pancreas systems, such that patients and their providers will have a choice for ongoing care of the best CGM and algorithm that fit each patient's needs. I applaud the researchers evaluating the clinical applications of such systems," says DTT Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver (Aurora).

Source-Eurekalert


Advertisement